|  Help  |  About  |  Contact Us

Publication : Mice transgenic for Alzheimer disease beta-amyloid develop lens cataracts that are rescued by antioxidant treatment.

First Author  Melov S Year  2005
Journal  Free Radic Biol Med Volume  38
Issue  2 Pages  258-61
PubMed ID  15607908 Mgi Jnum  J:94786
Mgi Id  MGI:3521526 Doi  10.1016/j.freeradbiomed.2004.10.023
Citation  Melov S, et al. (2005) Mice transgenic for Alzheimer disease beta-amyloid develop lens cataracts that are rescued by antioxidant treatment. Free Radic Biol Med 38(2):258-61
abstractText  Alzheimer disease is characterized by cerebral Abeta deposition, which we have recently discovered occurs also in the lens as cataracts in Alzheimer disease patients. Here we report the presence of significantly increased cataracts in the lenses of an Abeta-transgenic mouse model for Alzheimer disease and their amelioration upon treatment with EUK-189, a synthetic SOD/catalase mimetic. These data support an oxidative etiology for AD-associated lens cataracts and their potential to be treated preventatively with antioxidants.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

3 Bio Entities

0 Expression